Socrus Bio Sciences Financials

BSE: 524719

₹0.48

₹0.00 (0.00%)

As on 03-Aug-2015IST

Market cap

₹2 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Operating Revenue	1.17	19.89	30.16	22.08	5.70	5.32
Total Income	--	19.89	30.20	22.22	6.06	6.18
Total Expenditure	1.29	54.93	23.69	17.91	5.82	5.69
EBITDA	-0.12	-35.04	6.47	4.17	-0.13	-0.36
Depreciation	--	4.32	0.05	0.06	0.06	0.06
EBIT	-0.12	-39.36	6.42	4.11	-0.19	-0.43
Interest	--	0.00	0.00	0.00	0.09	0.40
Other Income	--	--	0.04	0.14	0.36	0.85
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.12	-39.36	6.46	4.24	0.08	0.02
Provision for Tax	--	--	1.33	-0.38	0.01	-0.22
Profit after Tax	-0.12	-39.36	5.12	4.62	0.07	0.24

Liabilities (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Shareholder's Funds	--	1.27	40.64	35.52	11.88	11.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	-0.63	-0.63	-1.96	-1.44	68.59
Current Liabilities	--	0.97	0.06	0.04	0.03	0.03
Total Liabilities	--	2.24	40.70	35.55	11.91	81.96

Assets (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Non-Current Assets	--	0.36	24.13	24.18	0.71	0.78
Current Assets	--	1.26	15.94	9.41	9.76	79.69
Total Assets	--	2.24	40.70	35.55	11.91	81.96
Total Debt*	--	--	--	--	--	70.07
Net Current Assets	--	0.29	15.88	9.37	9.72	79.66
Contingent Liabilities	--	1.33	1.33	1.33	1.33	1.03

Cashflow (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Cash From Operating Activities	--	-3.30	-0.06	3.30	69.98	-4.93
Cash Flow from Investing Activities	--	3.26	--	-22.18	-70.07	0.78
Cash from Financing Activities	--	--	--	18.91	--	3.92
Net Cash Inflow / Outflow	--	-0.04	-0.06	0.03	-0.09	-0.23

Financials Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Adjusted EPS (₹)	-0.04	-12.30	1.60	1.44	0.05	0.16
Cash EPS (₹)	--	-10.95	1.62	1.46	0.09	0.20
Adjusted Book Value (₹)	--	0.40	12.70	11.10	8.11	8.09
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-1.03	-0.02	1.03	47.76	-3.36
Free Cash Flow per Share (₹)	--	-5.75	-0.44	-0.20	-0.07	-3.20

Profitability Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
ROCE (%)	--	-187.83	16.96	17.92	0.36	0.53
ROE (%)	--	-187.84	13.45	19.51	0.60	2.00
ROA (%)	--	-188.87	13.91	20.98	0.16	0.30
EBIT Margin (%)	--	-197.92	21.28	18.61	-3.38	-8.06
Net Margin (%)	--	-197.92	16.96	20.81	1.17	3.81
Cash Profit Margin (%)	--	-176.21	17.14	21.23	2.38	5.63

Growth Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Revenue Growth (%)	--	-34.06	36.60	287.61	7.00	-44.03
EBIT Growth (%)	--	-713.36	56.20	--	55.17	-176.77
Net Profit Growth (%)	99.30	-868.59	10.79	6,430.15	-69.89	122.13
EPS Growth (%)	--	-868.59	10.79	2,889.88	-69.89	122.13
Book Value Growth (%)	--	-96.86	14.42	199.03	0.18	2.02

Valuation Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Price / Earnings	--	--	3.11	3.19	42.43	31.17
Price / Book Value	1.10	2.96	0.39	0.42	0.25	0.62
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-13.27	-0.11	2.44	3.40	12.81	157.89
Close Price (₹)	0.85	1.18	4.97	4.61	2.05	5.00
High Price (₹)	1.71	5.77	8.89	12.00	6.74	13.08
Low Price (₹)	0.57	1.08	2.39	2.90	1.57	1.54
Market Cap (₹ Cr)	1.54	3.78	15.91	14.75	3.00	7.33

Solvency Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debt to Equity	--	--	--	--	--	5.91
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	--	1.30	265.58	237.89	292.37	2,736.60
Quick Ratio	--	0.36	164.53	184.68	105.80	2,522.80
Interest Coverage	--	--	3,204.49	5,461.50	1.85	1.05

Operating Efficiency Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debtors to sales (%)	--	--	22.62	24.17	12.71	10.28
Asset Turnover	--	0.95	0.82	1.00	0.13	0.07
Receivable days	--	--	73.58	50.10	40.72	38.00
Inventory Days	--	63.94	49.43	68.86	398.95	438.28
Payable days	--	5.60	0.72	0.43	0.37	6.63
Cash Conversion Cycle	--	58.34	122.29	118.53	439.30	469.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.